在近距离诱导药物药理学中应用共价模式:早期发展,当前战略和特征方向
Linjie Li1, Song Liu1, Youfu Luo1
1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China.
European journal of medicinal chemistry
|April 21, 2024
概括
联药物正在获得FDA对癌症和其他疾病的批准,显示了对这种强效治疗策略的重新兴趣. 本综述探讨了近距离诱导分子的共价模式,强调了它们的好处和局限性.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 药理学 药理学是指药理学的学科.
背景情况:
- 共同药物越来越多地得到FDA的批准,特别是用于癌症治疗.
- 在学术界和生物制药行业内,人们对共价调制策略的兴趣正在复苏.
- 相对于非共价药物,共价化学具有优势,比如提高功效和准"无法治疗"的目标.
研究的目的:
- 为提供当前用于近距离诱导分子的共价模式的全面概述.
- 讨论这些共价策略的优点和缺点.
- 激发科学洞察力,指导未来对共价药物开发的研究.
主要方法:
- 对共价药物模式的文献综述.
- 分析共价方法与非共价方法的优缺点.
- 药物发现的共价化学当前趋势和未来方向的综合.
主要成果:
- 共价药物显示出显著的治疗成功,特别是在瘤学中.
- 关键优势包括增强的功效,较小的分子尺寸,以及针对具有挑战性的生物实体的能力.
- 确定并讨论了当前共价模式的缺点和局限性.
结论:
- 共价药物策略非常有前途,正在快速发展.
- 对近距离诱导分子的共价模式的进一步研究是有必要的.
- 这个领域有潜力开发各种疾病的新疗法,包括那些目前被认为是"无药"的疾病.
相关概念视频
Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K
Pharmacodynamics: Overview and Principles
1.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.1K
Quantitative Aspects of Drug-Receptor Interaction
977
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
977
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Inductive Effects on Chemical Shift: Overview
1.1K
The protons in unsubstituted alkanes are strongly shielded with chemical shifts below 1.8 ppm. Methine, methylene, and methyl protons appear at approximately 1.7, 1.2 and 0.7 ppm, while the proton signal from methane appears at 0.23 ppm. An electronegative substituent, such as chlorine, withdraws the electron density from the protons, increasing their chemical shift. Progressive substitution of the hydrogens in methane by chlorine shifts the proton signals increasingly downfield, to 3.05 ppm in...
1.1K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K


